Publications by authors named "David Witcombe"

Claim this Profile
T
The epidemiology, management, and the associated burden of migraine in Australian primary care: a retrospective analysis of electronic health record data.
Nicole Limberg, Jason C Ray, Benjamin Harvey, Giles Stratton, Angus Cuskelly, David Witcombe

J Headache Pain· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychosocial and Occupational Burden on Caregivers of Adolescents With Alopecia Areata in Australia.
Rodney Sinclair, Samantha Eisman, Carol M Y Lee, Maureen Hitschfeld, Komal Kapoor, David Witcombe

Australas J Dermatol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimated Incidence of Hospitalisations and Deaths Attributable to Respiratory Syncytial Virus Infections in Adults in Australia Between 2010 and 2019.
Zirke Wiid, Caihua Liang, Robin Bruyndonckx, Lauren Mason, Aleksandra Polkowska-Kramek, David Witcombe

Influenza Other Respir Viruses· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life of adult and adolescent patients living with alopecia areata in Australia.
Rodney Sinclair, Samantha Eisman, Carol M Y Lee, Maureen Hitschfeld, David Witcombe

Australas J Dermatol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world evaluation of persistence, effectiveness and usage patterns of tofacitinib in treatment of psoriatic arthritis in Australia.
Geoffrey Littlejohn, Joanna Leadbetter, Belinda E Butcher, Marie Feletar, Catherine O'Sullivan, David Witcombe

Clin Rheumatol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world evaluation of effectiveness, persistence, and usage patterns of monotherapy and combination therapy tofacitinib in treatment of rheumatoid arthritis in Australia.
Paul Bird, Geoffrey Littlejohn, Belinda Butcher, Tegan Smith, Catherine O'Sullivan, David Witcombe

Clin Rheumatol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ulcerative Colitis Narrative findings: Australian survey data comparing patient and physician disease management views.
Susan J Connor, Alexandra Sechi, Mauricio Andrade, J Jasper Deuring, David Witcombe

JGH Open· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient Perceptions of Psoriatic Arthritis Management and Communication with Physicians in Australia: Results from a Patient Survey.
Irwin Lim, Pascal Richette, Ruben Queiro-Silva, Jade Moser, Joseph C Cappelleri, David Witcombe

Rheumatol Ther· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world evaluation of effectiveness, persistence, and usage patterns of tofacitinib in treatment of rheumatoid arthritis in Australia.
Paul Bird, Geoffrey Littlejohn, Belinda Butcher, Tegan Smith, Candida da Fonseca Pereira, David Witcombe

Clin Rheumatol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment outcomes in patients with seropositive versus seronegative rheumatoid arthritis in Phase III randomised clinical trials of tofacitinib.
Paul Bird, Stephen Hall, Peter Nash, Carol A Connell, Kenneth Kwok, David Witcombe

RMD Open· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tofacitinib 5 mg Twice Daily in Patients with Rheumatoid Arthritis and Inadequate Response to Disease-Modifying Antirheumatic Drugs: A Comprehensive Review of Phase 3 Efficacy and Safety.
Paul Bird, William Bensen, Bassel El-Zorkany, Jeffrey Kaine, Bernadette Heizel Manapat-Reyes, David Witcombe

J Clin Rheumatol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tofacitinib, an Oral Janus Kinase Inhibitor: Pooled Efficacy and Safety Analyses in an Australian Rheumatoid Arthritis Population.
Stephen Hall, Peter Nash, Maureen Rischmueller, David Bossingham, Paul Bird, David Witcombe

Rheumatol Ther· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strategies for anti-coccidial prophylaxis.
David M Witcombe, Nicholas C Smith

Parasitology· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterisation of the antigenic and immunogenic properties of bacterially expressed, sexual stage antigens of the coccidian parasite, Eimeria maxima.
Sabina I Belli, Kelly Mai, Caroline D Skene, Michelle T Gleeson, David M Witcombe

Vaccine· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eimeria maxima TRAP family protein EmTFP250: subcellular localisation and induction of immune responses by immunisation with a recombinant C-terminal derivative.
David M Witcombe, David J P Ferguson, Sabina I Belli, Michael G Wallach, Nicholas C Smith

Int J Parasitol· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular characterisation of EmTFP250: a novel member of the TRAP protein family in Eimeria maxima.
David M Witcombe, Sabina I Belli, Michael G Wallach, Nicholas C Smith

Int J Parasitol· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional genomics of gam56: characterisation of the role of a 56 kilodalton sexual stage antigen in oocyst wall formation in Eimeria maxima.
Sabina I Belli, David Witcombe, Michael G Wallach, Nicholas C Smith

Int J Parasitol· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis